Palvella Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	940	130	-	-
Enterprise Value	899	208	-	-
PB Ratio	28.52	2.15	-	-
P/TBV Ratio	28.52	2.15	-	-
Debt / Equity Ratio	0.41	0.19	-2.08	-1.40
Quick Ratio	6.38	7.14	3.11	2.78
Current Ratio	6.49	7.33	3.20	2.86
Return on Equity (ROE)	-301.19%	-59.37%	-	-
Return on Assets (ROA)	-47.54%	-18.39%	-61.63%	-
Return on Capital (ROIC)	-63.87%	-22.38%	-110.58%	-
Return on Capital Employed (ROCE)	-55.90%	-18.50%	-228.80%	-167.90%
Earnings Yield	-2.93%	-12.95%	-	-
Buyback Yield / Dilution	-60.51%	-24.08%	68.63%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.